98%
921
2 minutes
20
The movements of syringes and medications during an anesthetic case have yet to be systematically documented. We examine how syringes and medication move through the anesthesia work area during a case. We conducted a video-based observational study of 14 laparoscopic surgeries. We defined 'syringe events' as when syringe was picked up and moved. Medications were administered to the patient in only 48 (23.6%) of the 203 medication or syringe events. On average, 14.5 syringe movements occurred in each case. We estimate approximately 4.2 syringe movements for each medication administration. When a medication was administered to the patient (either through the IV pump or the patient port), it was picked up from one of 8 locations in the work area. Our study suggests that the syringe storage locations vary and include irregular locations (e.g., patient bed or provider's pockets). Our study contributes to understanding the complexity in the anesthesia work practices.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11230132 | PMC |
http://dx.doi.org/10.1016/j.apergo.2024.104263 | DOI Listing |
Cureus
August 2025
Department of Diagnostic Radiology, King Edward Medical University, Lahore, PAK.
Objective To evaluate the effectiveness of ultrasound-guided marker placement in the precise localization of breast lesions, facilitate accurate surgical resection, and monitor tumor response during and after neoadjuvant chemotherapy. Materials and methods From January 2022 to December 2022, 70 female patients with breast carcinoma underwent a trial of metallic marker insertion into the tumor. The markers were made by cutting 5CC disposable syringe needles having a total length of 5 mm.
View Article and Find Full Text PDFPLoS One
September 2025
Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.
Background: One of the most important occupational injuries experienced by nurses is needle sticks. The causes and factors of needle sticks are not fully known. This study was conducted with the aim of investigating the relationship between sensation-seeking, aggressiveness, and self-confidence with needle stick and Sharp injuries among nurses in a children's and women's hospital.
View Article and Find Full Text PDFAdv Ther
September 2025
Eli Lilly and Company, Lilly Corporate Center, 893 Delaware Street, Indianapolis, IN, 46225, USA.
Introduction: Mirikizumab, a humanized anti-interleukin-23p19 monoclonal antibody, is approved for the treatment of moderate-to-severe ulcerative colitis (UC) and Crohn's disease (CD). Two phase 1, open-label, two-arm, randomized studies compared pharmacokinetics and safety of mirikizumab (200 mg, Study AMBW; 300 mg, Study AMBX) to establish bioequivalence. Mirikizumab was administered subcutaneously using an autoinjector or a prefilled syringe (PFS) as a single dose in healthy participants.
View Article and Find Full Text PDFJ Addict Dis
September 2025
Department of Psychiatry and Behavioral Health, Ohio State University Wexner Medical Center Talbot Hall, Columbus, OH, USA.
Background: Comorbidity between opioid use disorder (OUD) and chronic pain is substantial. Pain has been shown to be a motivator for OUD onset, maintenance, relapse, and treatment delay. A cluster of pain conditions known as chronic overlapping pain conditions (COPCs), also now referred to in contemporary ICD classification as primary pain conditions, are particularly refractory to traditional forms of pain treatment, and likely adversely impact comorbid OUD.
View Article and Find Full Text PDFHealth Aff (Millwood)
September 2025
Pooja Lagisetty, University of Michigan, Ann Arbor, Michigan.
A central challenge in the opioid crisis in the US has been the underuse of lifesaving treatment and harm reduction programs. Conventional explanations focus on limited access to care when services are not convenient, affordable, or timely. However, these factors exist downstream from other fundamental causes of low utilization.
View Article and Find Full Text PDF